BD BBL™ CHROMAGAR® CANDIDA - COFEPRIS Registration 788R2018 SSA
Access comprehensive regulatory information for BD BBL™ CHROMAGAR® CANDIDA (BD BBL™ CHROMAGAR® CANDIDA) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 788R2018 SSA and manufactured by BECTON DICKINSON DE MÉXICO, S.A. DE C.V.. The device was registered on March 21, 2018.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
EL BD BBL CHROMAGAR® CANDIDA ES UN MEDIO SELECTIVO PARA EL AISLAMIENTO E IDENTIFICACIÓN PRESUNTIVA DE LEVADURAS Y HONGOS FILAMENTOSOS, PARA LA DIFERENCIACIÓN DE C. ALBICANS, C. TROPICALIS Y C. KRUSEI. AGENTE DE DIAGNÓSTICO, USO IN VITRO. PARA USO EXCLU
BD BBL CHROMAGAR® CANDIDA IS A SELECTIVE MEDIUM FOR THE ISOLATION AND PRESUMPTIVE IDENTIFICATION OF YEASTS AND FILAMENTOUS FUNGI, FOR THE DIFFERENTIATION OF C. ALBICANS, C. TROPICALIS AND C. KRUSEI. DIAGNOSTIC AGENT, IN VITRO USE. FOR EXCLUSIVE USE